Ampersand Biomedicines presents preclinical data on AMP-220, a gut-targeted IL-22 AND-Body therapeutic, at AAI 2026: Boston Tuesday, April 21, 2026, 17:00 Hrs [IST] Ampersand Biom ...

A robust and quantitative map links chromatin modification and gene expression of cells during zebrafish embryogenesis.

Welo Global today launched as the new parent brand overseeing a portfolio of brands aligned to specific customer segments, ...

As the global generative AI boom shifts from scale to localization, Southeast Asia is emerging as a critical testing ground ...

Scientists have uncovered a novel mechanism through which skin cells organize and control protein production during ...

The brand promise has shifted from uniformity to curation. Most hospitality companies are still organized to enforce ...

In 2026, digitalization continues to evolve. Companies are not constrained any more to only local markets. Even small pr ...

ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a ...

Before entering a new market or finalizing any technical approach, discovery is essential.

In response to US semiconductor sanctions and to accelerate AI industry development, China is aggressively promoting ...

Giant migrating contractions (GMCs) are powerful waves of colonic movement that propel intestinal contents toward the anus ...